View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/FDA | RIN: 0910-AG07 | Publication ID: Spring 2011 |
| Title: Conditional Approval of New Animal Drugs for Minor Use and Minor Species | |
| Abstract: This proposed rule implements section 571 of the Food, Drug, and Cosmetic Act. The Minor Use and Minor Species Animal Health Act of 2004 (MUMS act) added three sections to the Federal Food, Drug, and Cosmetic Act (the Act) (571, 572, and 573), and it established new regulatory procedures intended to make more medications legally available to veterinarians and animal owners for the treatment of minor animal species, as well as uncommon diseases in major animal species. Section 571 of the Act provides for animal drug conditional approval after all safety and manufacturing components of a new animal drug approval have met the standards of section 512 of the Act. For the effectiveness component of a new animal drug review, a reasonable expectation of effectiveness must be established prior to conditional approval under section 571 of the Act. Sponsors then have up to 5 years to complete the demonstration of effectiveness by the standards of section 512 of the Act and achieve a complete new animal drug approval. | |
| Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Long-Term Actions |
| Major: No | Unfunded Mandates: No |
| CFR Citation: 21 CFR 516 | |
| Legal Authority: 21 USC 360ccc 21 USC 371(a) | |
Legal Deadline:
|
||||||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Small Entities Affected: Businesses | Federalism: No |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Urvi Desai Regulatory Counsel Department of Health and Human Services Food and Drug Administration Center for Veterinary Medicine, MPN1 Room 203 HFV-100, 7520 Standish Place, Rockville, MD 20855 Phone:240 276-8304 Fax:240 276-8297 Email: urvi.desai@fda.hhs.gov |
|
An official website of the United States government



